These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34332889)

  • 1. Invasive Assessment of Microvascular Resistance in Hypertrophic Cardiomyopathy With Echocardiographic Correlates.
    Bakar SN; Hayman S; McCarty D; Thain AP; McLellan A; Wagner C; Lavi S
    Heart Lung Circ; 2022 Feb; 31(2):194-198. PubMed ID: 34332889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of coronary blood flow in hypertrophic cardiomyopathy using thrombolysis in myocardial infarction frame count method.
    Yasar AS; Turhan H; Erbay AR; Karabal O; Bicer A; Sasmaz H; Yetkin E
    J Invasive Cardiol; 2005 Feb; 17(2):73-6. PubMed ID: 15687528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Young patients with hypertrophic cardiomyopathy, but not subjects at risk, show decreased myocardial perfusion reserve quantified with CMR.
    Gyllenhammar T; Fernlund E; Jablonowski R; Jögi J; Engblom H; Liuba P; Arheden H; Carlsson M
    Eur Heart J Cardiovasc Imaging; 2014 Dec; 15(12):1350-7. PubMed ID: 25139907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Index of microcirculatory resistance in the assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Aguiar Rosa S; Mota Carmo M; Rocha Lopes L; Oliveira E; Thomas B; Baquero L; Cruz Ferreira R; Fiarresga A
    Rev Port Cardiol; 2022 Sep; 41(9):761-767. PubMed ID: 36066271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: the index of microvascular resistance.
    Gutiérrez-Barrios A; Camacho-Jurado F; Díaz-Retamino E; Gamaza-Chulián S; Agarrado-Luna A; Oneto-Otero J; Del Rio-Lechuga A; Benezet-Mazuecos J
    Cardiovasc Revasc Med; 2015; 16(7):426-8. PubMed ID: 26235975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial blood flow and left ventricular functional reserve in hypertrophic cardiomyopathy: a
    Sciagrà R; Calabretta R; Cipollini F; Passeri A; Castello A; Cecchi F; Olivotto I; Pupi A
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):866-875. PubMed ID: 28050630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of coronary flow reserve in patients with hypertrophic cardiomyopathy using transthoracic color Doppler echocardiography].
    Asami Y; Yoshida K; Hozumi T; Akasaka T; Takagi T; Kaji S; Kawamoto T; Ogata Y; Yagi T; Morioka S; Yoshikawa J
    J Cardiol; 1998 Oct; 32(4):247-52. PubMed ID: 9833231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of left ventricular systolic and diastolic abnormalities in patients with hypertrophic cardiomyopathy using real-time three-dimensional echocardiography and two-dimensional speckle tracking imaging.
    Huang X; Yue Y; Wang Y; Deng Y; Liu L; Di Y; Sun S; Chen D; Fan L; Cao J
    Cardiovasc Ultrasound; 2018 Oct; 16(1):23. PubMed ID: 30285887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
    Dryer K; Gajjar M; Narang N; Lee M; Paul J; Shah AP; Nathan S; Butler J; Davidson CJ; Fearon WF; Shah SJ; Blair JEA
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H1033-H1042. PubMed ID: 29424571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary flow reserve impairment in apical vs asymmetrical septal hypertrophic cardiomyopathy.
    Ahn HS; Kim HK; Park EA; Lee W; Kim YJ; Cho GY; Park JH; Sohn DW
    Clin Cardiol; 2013 Apr; 36(4):207-16. PubMed ID: 23378014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Two types of exercise-induced abnormal blood pressure response in hypertrophic cardiomyopathy].
    Hu XY; Sun XG; Qiao SB; Gao XJ; Luo XL; Liu F; Zhang Y; Hao L; Song Y; Chen YZ; Wang JN; Tai WQ; Shi C; Xu F; Zhai WX; Yang J; Zhang TJ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Jan; 37(1):27-33. PubMed ID: 34672459
    [No Abstract]   [Full Text] [Related]  

  • 15. Left ventricular systolic dysfunction during exercise and dobutamine stress in patients with hypertrophic cardiomyopathy.
    Okeie K; Shimizu M; Yoshio H; Ino H; Yamaguchi M; Matsuyama T; Yasuda T; Taki J; Mabuchi H
    J Am Coll Cardiol; 2000 Sep; 36(3):856-63. PubMed ID: 10987611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Right ventricular function in hypertrophic cardiomyopathy: A speckle tracking echocardiography study.
    Cincin A; Tigen K; Karaahmet T; Dündar C; Gürel E; Bulut M; Sünbül M; Başaran Y
    Anatol J Cardiol; 2015 Jul; 15(7):536-41. PubMed ID: 25537994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy.
    Ha JW; Ahn JA; Kim JM; Choi EY; Kang SM; Rim SJ; Jang Y; Shim WH; Cho SY; Oh JK; Chung N
    J Am Soc Echocardiogr; 2006 Nov; 19(11):1314-9. PubMed ID: 17098132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced global myocardial perfusion reserve in DCM and HCM patients assessed by CMR-based velocity-encoded coronary sinus flow measurements and first-pass perfusion imaging.
    Bietenbeck M; Florian A; Shomanova Z; Meier C; Yilmaz A
    Clin Res Cardiol; 2018 Nov; 107(11):1062-1070. PubMed ID: 29774406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of intravascular and extravascular mechanisms of myocardial perfusion abnormalities in obstructive hypertrophic cardiomyopathy by myocardial contrast echocardiography.
    Soliman OI; Knaapen P; Geleijnse ML; Dijkmans PA; Anwar AM; Nemes A; Michels M; Vletter WB; Lammertsma AA; ten Cate FJ
    Heart; 2007 Oct; 93(10):1204-12. PubMed ID: 17488767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function.
    Yakar Tülüce S; Tülüce K; Çil Z; Emren SV; Akyıldız Zİ; Ergene O
    Anatol J Cardiol; 2016 May; 16(5):344-8. PubMed ID: 26488381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.